` BIM (Biomerieux SA) vs DAX Index Comparison - Alpha Spread

BIM
vs
DAX Index

Over the past 12 months, BIM has underperformed DAX Index, delivering a return of 19% compared to the DAX Index's 19% growth.

Stocks Performance
BIM vs DAX Index

Loading

Performance Gap
BIM vs DAX Index

Loading
BIM
DAX Index
Difference

Performance By Year
BIM vs DAX Index

Loading
BIM
DAX Index
Add Stock

Competitors Performance
Biomerieux SA vs Peers

Biomerieux SA
Glance View

Economic Moat
None
Market Cap
14B EUR
Industry
Health Care

In the world of clinical diagnostics, bioMérieux SA emerges as a formidable player, weaving together a tapestry of innovation, precision, and reliability. Founded in 1963 by Alain Mérieux, the company has its roots deeply embedded in Lyon, France, where a legacy of scientific prowess meets a global vision. bioMérieux specializes in in vitro diagnostics, creating a broad array of products and solutions that essentially serve as the medical community’s early warning systems. Their expertise spans across fields like microbiology, immunoassays, and molecular biology, where they craft diagnostic kits and automated instruments that empower healthcare providers to detect and prevent diseases with remarkable accuracy. By tapping into a robust network of research and development, bioMérieux collaborates with hospitals, laboratories, and public health organizations worldwide to address both routine and critical diagnostic needs. At the heart of bioMérieux’s business is its razor-sharp focus on infectious diseases, a sector that has seen accelerated growth in recent years, particularly with the advent of global health challenges such as the COVID-19 pandemic. The firm generates revenue through the sale of its diagnostic solutions and related services, offering comprehensive testing systems that include reagents and consumables, maintenance contracts, and training for laboratory professionals. Their continuous investment in innovation allows them to expand their product portfolio and tailor solutions to the evolving needs of the healthcare industry. By maintaining a pulse on global health trends and investing in cutting-edge technologies, bioMérieux not only secures its market position but also plays a crucial role in strengthening global public health infrastructure.

BIM Intrinsic Value
112.67 EUR
Overvaluation 5%
Intrinsic Value
Price
Back to Top